Stock listing

COV Stock Price, News, Filings & Events — Cleo Diagnostics Ltd

Selected listing: COV · ASX · AUD · AU

This page tracks Cleo Diagnostics Ltd's COV:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following COV:ASX. COV:ASX is the stock-level entry point for investors researching Cleo Diagnostics Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cleo Diagnostics Ltd, trading under the ticker COV, is a public company based in Australia with a market capitalization of approximately AUD 33.4 million. The company focuses on innovative diagnostic solutions in the healthcare sector. Cleo Diagnostics aims to enhance patient care through advanced technology and research.

COV:ASXAUDAUUpdated August 21, 2026
Cleo Diagnostics Ltd logo
Ticker
COV:ASX
Asset type
Stock
Market cap
$32.2M
Sector
Health Technology
Industry
Medical Specialties
Exchange
ASX
Currency
AUD

Cleo Diagnostics Ltd COV:ASX stock context

This page tracks Cleo Diagnostics Ltd's COV:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following COV:ASX. COV:ASX is the stock-level entry point for investors researching Cleo Diagnostics Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cleo Diagnostics Ltd, trading under the ticker COV, is a public company based in Australia with a market capitalization of approximately AUD 33.4 million. The company focuses on innovative diagnostic solutions in the healthcare sector. Cleo Diagnostics aims to enhance patient care through advanced technology and research.

Latest news from Cleo Diagnostics Ltd

All Cleo Diagnostics Ltd news →

Research Cleo Diagnostics Ltd

Alternate listings